Avanos Medical, Inc(NYSE:AVNS) 
Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include d...
Website: http://avanos.com
Founded: 2014
Full Time Employees: 4,700
Sector: Healthcare
Industry: Medical Devices
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net sales | 180,900,000 | 177,800,000 | 175,000,000 | 167,500,000 | 179,600,000 | 170,400,000 | 171,700,000 | 166,100,000 | 173,300,000 | 171,300,000 | 169,400,000 | 191,700,000 | 217,500,000 | 202,100,000 | 203,000,000 | 197,400,000 | 193,400,000 | 184,100,000 | 186,400,000 | 180,700,000 | 185,000,000 | 185,700,000 | 163,700,000 | 180,400,000 | 189,800,000 | 171,400,000 | 172,200,000 | 164,200,000 | 169,900,000 | 165,100,000 | 160,900,000 | 156,400,000 | -584,600,000 | 401,400,000 | 399,200,000 | 395,600,000 | 410,000,000 | 397,500,000 | 400,000,000 | 384,800,000 | 401,400,000 | 389,500,000 | 389,300,000 | 394,200,000 | 439,400,000 | 408,500,000 |
yoy | 0.72% | 4.34% | 1.92% | 0.84% | 3.64% | -0.53% | 1.36% | -13.35% | -20.32% | -15.24% | -16.55% | -2.89% | 12.46% | 9.78% | 8.91% | 9.24% | 4.54% | -0.86% | 13.87% | 0.17% | -2.53% | 8.34% | -4.94% | 9.87% | 11.71% | 3.82% | 7.02% | 4.99% | -129.06% | -58.87% | -59.69% | -60.47% | -242.59% | 0.98% | -0.20% | 2.81% | 2.14% | 2.05% | 2.75% | -2.38% | -8.65% | -4.65% | ||||
qoq | 1.74% | 1.60% | 4.48% | -6.74% | 5.40% | -0.76% | 3.37% | -4.15% | 1.17% | 1.12% | -11.63% | -11.86% | 7.62% | -0.44% | 2.84% | 2.07% | 5.05% | -1.23% | 3.15% | -2.32% | -0.38% | 13.44% | -9.26% | -4.95% | 10.74% | -0.46% | 4.87% | -3.35% | 2.91% | 2.61% | 2.88% | -126.75% | -245.64% | 0.55% | 0.91% | -3.51% | 3.14% | -0.62% | 3.95% | -4.14% | 3.06% | 0.05% | -1.24% | -10.29% | 7.56% | |
cost of products sold | 94,900,000 | 91,800,000 | 82,900,000 | 77,700,000 | 81,600,000 | 77,500,000 | 76,100,000 | 71,300,000 | 78,300,000 | 75,800,000 | 71,600,000 | 87,200,000 | 100,600,000 | 92,000,000 | 88,100,000 | 90,200,000 | 96,500,000 | 93,700,000 | 100,700,000 | 89,400,000 | 96,100,000 | 89,900,000 | 77,200,000 | 78,300,000 | 80,100,000 | 76,400,000 | 73,500,000 | 65,400,000 | 69,500,000 | 60,400,000 | 66,200,000 | 65,300,000 | -490,700,000 | 258,100,000 | 254,600,000 | 252,700,000 | 267,300,000 | 259,500,000 | 259,300,000 | 248,300,000 | 193,750,000 | 258,500,000 | 254,400,000 | 262,100,000 | 210,150,000 | 276,300,000 |
gross profit | 86,000,000 | 86,000,000 | 92,100,000 | 89,800,000 | 98,000,000 | 92,900,000 | 95,600,000 | 94,800,000 | 95,000,000 | 95,500,000 | 97,800,000 | 104,500,000 | 116,900,000 | 110,100,000 | 114,900,000 | 107,200,000 | 96,900,000 | 90,400,000 | 85,700,000 | 91,300,000 | 88,900,000 | 95,800,000 | 86,500,000 | 102,100,000 | 109,700,000 | 95,000,000 | 98,700,000 | 98,800,000 | 100,400,000 | 104,700,000 | 94,700,000 | 91,100,000 | -93,900,000 | 143,300,000 | 144,600,000 | 142,900,000 | 142,700,000 | 138,000,000 | 140,700,000 | 136,500,000 | 133,600,000 | 131,000,000 | 134,900,000 | 132,100,000 | 156,500,000 | 132,200,000 |
yoy | -12.24% | -7.43% | -3.66% | -5.27% | 3.16% | -2.72% | -2.25% | -9.28% | -18.73% | -13.26% | -14.88% | -2.52% | 20.64% | 21.79% | 34.07% | 17.42% | 9.00% | -5.64% | -0.92% | -10.58% | -18.96% | 0.84% | -12.36% | 3.34% | 9.26% | -9.26% | 4.22% | 8.45% | -206.92% | -26.94% | -34.51% | -36.25% | -165.80% | 3.84% | 2.77% | 4.69% | 6.81% | 5.34% | 4.30% | 3.33% | -14.63% | -0.91% | ||||
qoq | 0.00% | -6.62% | 2.56% | -8.37% | 5.49% | -2.82% | 0.84% | -0.21% | -0.52% | -2.35% | -6.41% | -10.61% | 6.18% | -4.18% | 7.18% | 10.63% | 7.19% | 5.48% | -6.13% | 2.70% | -7.20% | 10.75% | -15.28% | -6.93% | 15.47% | -3.75% | -0.10% | -1.59% | -4.11% | 10.56% | 3.95% | -197.02% | -165.53% | -0.90% | 1.19% | 0.14% | 3.41% | -1.92% | 3.08% | 2.17% | 1.98% | -2.89% | 2.12% | -15.59% | 18.38% | |
gross margin % | 47.54% | 48.37% | 52.63% | 53.61% | 54.57% | 54.52% | 55.68% | 57.07% | 54.82% | 55.75% | 57.73% | 54.51% | 53.75% | 54.48% | 56.60% | 54.31% | 50.10% | 49.10% | 45.98% | 50.53% | 48.05% | 51.59% | 52.84% | 56.60% | 57.80% | 55.43% | 57.32% | 60.17% | 59.09% | 63.42% | 58.86% | 58.25% | 16.06% | 35.70% | 36.22% | 36.12% | 34.80% | 34.72% | 35.17% | 35.47% | 33.28% | 33.63% | 34.65% | 33.51% | 35.62% | 32.36% |
research and development | 6,100,000 | 6,000,000 | 5,800,000 | 5,400,000 | 5,700,000 | 7,200,000 | 6,300,000 | 7,000,000 | 6,800,000 | 6,100,000 | 6,800,000 | 7,900,000 | 7,500,000 | 7,300,000 | 8,000,000 | 7,800,000 | 7,600,000 | 8,400,000 | 8,000,000 | 8,300,000 | 9,600,000 | 8,200,000 | 7,700,000 | 9,400,000 | 8,400,000 | 9,600,000 | 9,500,000 | 10,200,000 | 10,600,000 | 10,500,000 | 10,800,000 | 9,900,000 | 10,100,000 | 10,300,000 | 9,800,000 | 8,000,000 | 12,000,000 | 10,900,000 | 9,500,000 | 8,700,000 | ||||||
selling and general expenses | 78,800,000 | 77,600,000 | 83,500,000 | 75,700,000 | 79,700,000 | 74,300,000 | 80,900,000 | 83,600,000 | 74,500,000 | 78,700,000 | 93,000,000 | 92,700,000 | 82,600,000 | 82,100,000 | 87,100,000 | 90,100,000 | 75,200,000 | 75,000,000 | 76,700,000 | 73,400,000 | 82,200,000 | 82,400,000 | 76,900,000 | 91,100,000 | 103,600,000 | 94,400,000 | 94,700,000 | 106,400,000 | 87,900,000 | 86,300,000 | 79,800,000 | 86,400,000 | 19,200,000 | 101,200,000 | 100,100,000 | 101,200,000 | 110,100,000 | 100,300,000 | 107,900,000 | 92,800,000 | 98,300,000 | 97,200,000 | 105,800,000 | 97,200,000 | 126,400,000 | 111,300,000 |
goodwill impairment | 19,250,000 | 77,000,000 | -1,500,000 | 475,500,000 | ||||||||||||||||||||||||||||||||||||||||||
other expense | -1,400,000 | 2,300,000 | 300,000 | -1,600,000 | -5,600,000 | -600,000 | 2,100,000 | 200,000 | 2,500,000 | 9,500,000 | 100,000 | 1,300,000 | 600,000 | 2,000,000 | 800,000 | 100,000 | -10,900,000 | 3,400,000 | 8,300,000 | 22,000,000 | 41,900,000 | 5,300,000 | 3,700,000 | 1,000,000 | 900,000 | 9,100,000 | 4,300,000 | 6,800,000 | 10,200,000 | 900,000 | -4,700,000 | 1,800,000 | 4,200,000 | 3,000,000 | 5,500,000 | 7,400,000 | -500,000 | 9,300,000 | 700,000 | |||||||
operating income | 2,500,000 | 100,000 | -74,500,000 | 10,300,000 | -418,500,000 | 12,000,000 | 6,300,000 | 4,000,000 | 11,200,000 | 1,200,000 | -2,100,000 | 2,600,000 | 26,200,000 | 18,700,000 | 19,000,000 | 9,200,000 | 25,000,000 | 3,600,000 | -7,300,000 | -44,800,000 | -100,000 | -1,800,000 | 600,000 | -3,200,000 | -18,100,000 | -9,800,000 | -24,600,000 | -8,300,000 | 7,000,000 | 8,800,000 | -7,000,000 | |||||||||||||||
yoy | -100.60% | -99.17% | -1282.54% | 157.50% | -3836.61% | 900.00% | -400.00% | 53.85% | -57.25% | -93.58% | -111.05% | -71.74% | 4.80% | 419.44% | -360.27% | -155.80% | -3700.00% | 305.56% | 1300.00% | -99.45% | -81.63% | -102.44% | -61.45% | -358.57% | -211.36% | 251.43% | ||||||||||||||||||||
qoq | 2400.00% | -100.13% | -823.30% | -102.46% | -3587.50% | 90.48% | 57.50% | -64.29% | 833.33% | -157.14% | -180.77% | -90.08% | 40.11% | -1.58% | 106.52% | -63.20% | 594.44% | -149.32% | 44700.00% | -94.44% | -400.00% | -118.75% | -82.32% | 84.69% | -60.16% | 196.39% | -218.57% | -20.45% | -225.71% | |||||||||||||||||
operating margin % | 1.38% | 0.06% | -42.57% | 6.15% | -233.02% | 7.04% | 3.67% | 2.41% | 6.46% | 0.70% | -1.24% | 1.36% | 12.05% | 9.25% | 9.36% | 4.66% | 12.93% | 1.96% | -3.92% | 0% | -24.22% | -0.05% | -1.10% | 0.33% | -1.69% | -10.56% | -5.69% | -14.98% | -4.89% | 4.24% | 5.47% | -4.48% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
interest income | 600,000 | 500,000 | 600,000 | 1,500,000 | 800,000 | 700,000 | 3,000,000 | 600,000 | 1,000,000 | 900,000 | 500,000 | 500,000 | 700,000 | 300,000 | 200,000 | 200,000 | 100,000 | 200,000 | 200,000 | 700,000 | 1,000,000 | 1,300,000 | 2,000,000 | 2,400,000 | 2,400,000 | 2,200,000 | 2,200,000 | 1,000,000 | 900,000 | 700,000 | 500,000 | 400,000 | 100,000 | 200,000 | 100,000 | 200,000 | 100,000 | 100,000 | 100,000 | 1,000,000 | ||||||
interest expense | -1,900,000 | -1,800,000 | -2,000,000 | -2,100,000 | -2,800,000 | -3,200,000 | -3,100,000 | -3,100,000 | -3,300,000 | -4,700,000 | -3,500,000 | -3,500,000 | -3,000,000 | -3,000,000 | -2,700,000 | -1,300,000 | -700,000 | -900,000 | -900,000 | -800,000 | -2,700,000 | -4,300,000 | -4,300,000 | -4,300,000 | -4,300,000 | -3,500,000 | -3,500,000 | -3,700,000 | -3,500,000 | -4,200,000 | -9,900,000 | -8,800,000 | -8,100,000 | -8,100,000 | -7,800,000 | -7,600,000 | -8,000,000 | -8,400,000 | -8,300,000 | -8,000,000 | -8,100,000 | -7,800,000 | -8,900,000 | -8,300,000 | -5,900,000 | -100,000 |
income before income taxes | 1,200,000 | -1,200,000 | -75,900,000 | 9,700,000 | -420,500,000 | 9,500,000 | 6,200,000 | 1,500,000 | 8,900,000 | -2,600,000 | -5,100,000 | -400,000 | 23,900,000 | 16,000,000 | 16,500,000 | 7,900,000 | 24,300,000 | 2,900,000 | -8,200,000 | -13,200,000 | -47,400,000 | -4,200,000 | -5,900,000 | -3,000,000 | -6,500,000 | -20,300,000 | -11,300,000 | -25,900,000 | -9,400,000 | 5,000,000 | 1,100,000 | -14,800,000 | -134,600,000 | 21,400,000 | 21,900,000 | 19,100,000 | 7,900,000 | 12,700,000 | 9,400,000 | 25,300,000 | 12,500,000 | -469,000,000 | 13,300,000 | 32,700,000 | 18,100,000 | 14,000,000 |
income tax provision | -1,050,000 | -200,000 | -900,000 | -3,100,000 | -1,625,000 | -3,600,000 | -100,000 | -3,975,000 | -4,800,000 | -4,800,000 | -6,300,000 | 2,100,000 | -3,600,000 | -2,900,000 | -11,100,000 | |||||||||||||||||||||||||||||||
income from continuing operations | -17,900,000 | -1,400,000 | -76,800,000 | 6,600,000 | -397,000,000 | 5,900,000 | 4,300,000 | 500,000 | 11,000,000 | -8,800,000 | -4,300,000 | -9,950,000 | -11,500,000 | -8,000,000 | -1,450,000 | 4,200,000 | 1,300,000 | |||||||||||||||||||||||||||||
loss from discontinued operations, net of tax | -2,500,000 | |||||||||||||||||||||||||||||||||||||||||||||
net income | -1,300,000 | -1,400,000 | -76,800,000 | 6,600,000 | -397,300,000 | 4,300,000 | 1,800,000 | -900,000 | 10,500,000 | -3,700,000 | -68,100,000 | -500,000 | 16,900,000 | 15,700,000 | 11,400,000 | 5,800,000 | 10,000,000 | -35,100,000 | 37,900,000 | -7,600,000 | -47,200,000 | 19,300,000 | -3,000,000 | 3,700,000 | -6,100,000 | -11,500,000 | -8,000,000 | -20,300,000 | -2,200,000 | 4,200,000 | 35,300,000 | 20,200,000 | 32,800,000 | 16,600,000 | 17,100,000 | 12,800,000 | 10,000,000 | 9,100,000 | 6,500,000 | 14,200,000 | 14,500,000 | -470,500,000 | 8,000,000 | 21,700,000 | -2,400,000 | -7,400,000 |
yoy | -99.67% | -132.56% | -4366.67% | -833.33% | -3883.81% | -216.22% | -102.64% | 80.00% | -37.87% | -123.57% | -697.37% | -108.62% | 69.00% | -144.73% | -69.92% | -176.32% | -121.19% | -281.87% | -1363.33% | -305.41% | 673.77% | -267.83% | -62.50% | -118.23% | 177.27% | -373.81% | -122.66% | -200.50% | -106.71% | -74.70% | 106.43% | 57.81% | 228.00% | 82.42% | 163.08% | -9.86% | -31.03% | -101.93% | -18.75% | -34.56% | -704.17% | 6258.11% | ||||
qoq | -7.14% | -98.18% | -1263.64% | -101.66% | -9339.53% | 138.89% | -300.00% | -108.57% | -383.78% | -94.57% | 13520.00% | -102.96% | 7.64% | 37.72% | 96.55% | -42.00% | -128.49% | -192.61% | -598.68% | -83.90% | -344.56% | -743.33% | -181.08% | -160.66% | -46.96% | 43.75% | -60.59% | 822.73% | -152.38% | -88.10% | 74.75% | -38.41% | 97.59% | -2.92% | 33.59% | 28.00% | 9.89% | 40.00% | -54.23% | -2.07% | -103.08% | -5981.25% | -63.13% | -1004.17% | -67.57% | |
net income margin % | -0.72% | -0.79% | -43.89% | 3.94% | -221.21% | 2.52% | 1.05% | -0.54% | 6.06% | -2.16% | -40.20% | -0.26% | 7.77% | 7.77% | 5.62% | 2.94% | 5.17% | -19.07% | 20.33% | -4.21% | -25.51% | 10.39% | -1.83% | 2.05% | -3.21% | -6.71% | -4.65% | -12.36% | -1.29% | 2.54% | 21.94% | 12.92% | -5.61% | 4.14% | 4.28% | 3.24% | 2.44% | 2.29% | 1.63% | 3.69% | 3.61% | -120.80% | 2.05% | 5.50% | -0.55% | -1.81% |
basic earnings per share: | ||||||||||||||||||||||||||||||||||||||||||||||
continuing operations | -0.02 | -0.03 | -1.66 | 0.14 | -8.63 | 0.13 | 0.09 | 0.01 | 0.24 | -0.19 | -0.09 | -0.12 | -0.24 | -0.17 | -0.43 | -0.06 | 0.09 | 0.03 | -0.24 | |||||||||||||||||||||||||||
discontinued operations | -0.01 | -0.03 | -0.05 | -0.03 | -0.01 | 0.11 | -1.37 | 0.01 | 0.72 | 0.67 | ||||||||||||||||||||||||||||||||||||
basic earnings per share | -0.388 | -0.03 | -1.66 | 0.14 | -8.64 | 0.1 | 0.04 | 0.23 | -0.08 | -1.46 | -0.12 | -0.24 | -0.17 | -0.43 | -0.05 | 0.09 | 0.75 | 0.43 | ||||||||||||||||||||||||||||
diluted earnings per share: | ||||||||||||||||||||||||||||||||||||||||||||||
diluted earnings per share | -0.388 | -0.03 | -1.66 | 0.14 | -8.64 | 0.09 | 0.04 | 0.23 | -0.08 | -1.46 | -0.12 | -0.24 | -0.17 | -0.43 | -0.05 | 0.09 | 0.73 | 0.43 | ||||||||||||||||||||||||||||
income from discontinued operations, net of tax | -300,000 | -1,600,000 | -1,400,000 | -500,000 | 5,100,000 | -63,800,000 | 500,000 | 34,000,000 | 31,500,000 | |||||||||||||||||||||||||||||||||||||
income tax benefit | -1,900,000 | -1,000,000 | 2,100,000 | -6,200,000 | 800,000 | -7,000,000 | -300,000 | -5,100,000 | -2,100,000 | -14,300,000 | -38,000,000 | 46,100,000 | 5,600,000 | 200,000 | 23,500,000 | 2,900,000 | 6,700,000 | 400,000 | 8,800,000 | 3,300,000 | 5,600,000 | 6,700,000 | -800,000 | 200,000 | 3,500,000 | |||||||||||||||||||||
basic loss per share | -0.02 | |||||||||||||||||||||||||||||||||||||||||||||
diluted loss per share | -0.02 | |||||||||||||||||||||||||||||||||||||||||||||
earnings per share | ||||||||||||||||||||||||||||||||||||||||||||||
basic | -0.01 | 0.178 | 0.34 | 0.24 | 0.12 | -0.025 | -0.73 | 0.79 | -0.16 | 0.105 | 0.4 | -0.06 | 0.08 | 0.25 | 0.35 | 0.37 | 0.27 | 0.21 | 0.19 | |||||||||||||||||||||||||||
basic earnings per share | -0.388 | -0.03 | -1.66 | 0.14 | -8.64 | 0.1 | 0.04 | 0.23 | -0.08 | -1.46 | -0.12 | -0.24 | -0.17 | -0.43 | -0.05 | 0.09 | 0.75 | 0.43 | ||||||||||||||||||||||||||||
diluted | ||||||||||||||||||||||||||||||||||||||||||||||
earnings per share | ||||||||||||||||||||||||||||||||||||||||||||||
basic | -0.01 | 0.178 | 0.34 | 0.24 | 0.12 | -0.025 | -0.73 | 0.79 | -0.16 | 0.105 | 0.4 | -0.06 | 0.08 | 0.25 | 0.35 | 0.37 | 0.27 | 0.21 | 0.19 | |||||||||||||||||||||||||||
diluted | -0.01 | 0.178 | 0.33 | 0.24 | 0.12 | -0.025 | -0.73 | 0.78 | -0.16 | 0.105 | 0.4 | -0.06 | 0.08 | 0.245 | 0.35 | 0.36 | 0.27 | 0.22 | 0.19 | |||||||||||||||||||||||||||
operating profit | -12,400,000 | 21,075,000 | 28,800,000 | 29,200,000 | 26,300,000 | 15,800,000 | 20,900,000 | 17,600,000 | 33,100,000 | 20,500,000 | -461,200,000 | 22,100,000 | 40,900,000 | 24,000,000 | 13,100,000 | |||||||||||||||||||||||||||||||
earnings per share | ||||||||||||||||||||||||||||||||||||||||||||||
basic: | ||||||||||||||||||||||||||||||||||||||||||||||
diluted: | ||||||||||||||||||||||||||||||||||||||||||||||
loss from continuing operations | -20,300,000 | -11,300,000 | ||||||||||||||||||||||||||||||||||||||||||||
other expense and (income) | 4,800,000 | 5,900,000 | 5,700,000 | 1,900,000 | ||||||||||||||||||||||||||||||||||||||||||
per share basis | ||||||||||||||||||||||||||||||||||||||||||||||
basic | 0.14 | 0.3 | 0.31 | -10.1 | 0.17 | 0.47 | ||||||||||||||||||||||||||||||||||||||||
diluted | 0.14 | 0.3 | 0.31 | -10.1 | 0.17 | 0.46 | ||||||||||||||||||||||||||||||||||||||||
research and development expenses | 5,625,000 | 10,200,000 | 6,300,000 | 6,000,000 | 6,525,000 | 8,500,000 | ||||||||||||||||||||||||||||||||||||||||
provision for income taxes | 2,000,000 | -1,500,000 | -5,300,000 | -11,000,000 | ||||||||||||||||||||||||||||||||||||||||||
other income | -12,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
other (income) and expense | -1,400,000 | -700,000 | ||||||||||||||||||||||||||||||||||||||||||||
benefit from income taxes | -20,500,000 | -21,400,000 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||||||||||||||||||||||||||||
current assets | ||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | 89,800,000 | 70,500,000 | 90,300,000 | 97,000,000 | 107,700,000 | 89,000,000 | 92,200,000 | 75,800,000 | 87,700,000 | 107,100,000 | 81,800,000 | 95,700,000 | 127,700,000 | 117,000,000 | 106,500,000 | 104,300,000 | 118,500,000 | 97,800,000 | 99,900,000 | 100,100,000 | 111,500,000 | 180,000,000 | 185,000,000 | 187,700,000 | 205,300,000 | 214,400,000 | 288,100,000 | 348,300,000 | 384,500,000 | 411,800,000 | 479,600,000 | 203,100,000 | 219,700,000 | 166,100,000 | 154,800,000 | 143,100,000 | 113,700,000 | 86,700,000 | 79,200,000 | 165,100,000 | 129,500,000 | 112,500,000 | 114,300,000 | 166,200,000 | 149,000,000 | 58,400,000 |
accounts receivable | 103,800,000 | 111,500,000 | 110,200,000 | 104,800,000 | 132,800,000 | 131,900,000 | 123,000,000 | 131,300,000 | 142,800,000 | 145,200,000 | 152,300,000 | 142,700,000 | 167,900,000 | 146,200,000 | 145,400,000 | 161,600,000 | 118,200,000 | 117,500,000 | 106,700,000 | 105,300,000 | 108,600,000 | 182,300,000 | 137,800,000 | 159,600,000 | 163,800,000 | 157,700,000 | 124,300,000 | 135,000,000 | 150,500,000 | 151,800,000 | 189,200,000 | 199,500,000 | 203,000,000 | 194,400,000 | 184,100,000 | 181,200,000 | 190,100,000 | 189,100,000 | 195,200,000 | 206,300,000 | 224,700,000 | 204,400,000 | 200,100,000 | 226,500,000 | 233,900,000 | 192,200,000 |
inventories | 148,000,000 | 150,600,000 | 142,700,000 | 138,100,000 | 138,800,000 | 161,900,000 | 163,900,000 | 165,600,000 | 163,200,000 | 156,600,000 | 148,300,000 | 200,000,000 | 190,300,000 | 193,600,000 | 169,000,000 | 157,600,000 | 150,300,000 | 158,400,000 | 159,700,000 | 165,200,000 | 168,900,000 | 184,100,000 | 174,100,000 | 153,100,000 | 145,900,000 | 144,500,000 | 133,900,000 | 129,600,000 | 121,400,000 | 121,200,000 | 107,800,000 | 92,300,000 | 91,100,000 | 300,500,000 | 296,200,000 | 273,400,000 | 272,500,000 | 298,700,000 | 310,300,000 | 308,400,000 | 303,200,000 | 323,600,000 | 323,900,000 | 293,000,000 | 283,100,000 | 294,700,000 |
prepaid and other current assets | 13,800,000 | 18,800,000 | 12,800,000 | 12,500,000 | 14,100,000 | 15,900,000 | 22,300,000 | 28,600,000 | 28,800,000 | 13,600,000 | 15,800,000 | 15,400,000 | 13,900,000 | 13,200,000 | 16,200,000 | 15,700,000 | 18,600,000 | 18,900,000 | 23,500,000 | 57,200,000 | 14,400,000 | 17,200,000 | 18,600,000 | 16,800,000 | ||||||||||||||||||||||
total current assets | 355,400,000 | 351,400,000 | 356,000,000 | 352,400,000 | 393,400,000 | 472,600,000 | 474,100,000 | 467,800,000 | 487,000,000 | 524,600,000 | 506,900,000 | 453,800,000 | 499,800,000 | 470,000,000 | 437,100,000 | 439,200,000 | 418,600,000 | 405,000,000 | 443,500,000 | 447,900,000 | 467,200,000 | 567,600,000 | 517,100,000 | 524,100,000 | 538,500,000 | 546,500,000 | 572,500,000 | 660,000,000 | 713,600,000 | 737,200,000 | 876,500,000 | 1,161,100,000 | 1,160,700,000 | 681,000,000 | 654,800,000 | 614,400,000 | 593,500,000 | 605,600,000 | 609,700,000 | 706,600,000 | 676,000,000 | 666,000,000 | 653,100,000 | 703,100,000 | 684,900,000 | 596,100,000 |
property, plant and equipment | 113,400,000 | 115,400,000 | 114,300,000 | 109,800,000 | 110,700,000 | 109,500,000 | 110,700,000 | 116,200,000 | 117,200,000 | 116,800,000 | 122,600,000 | 163,500,000 | 163,900,000 | 163,400,000 | 164,300,000 | 166,900,000 | 168,100,000 | 169,700,000 | 171,900,000 | 173,400,000 | 175,300,000 | 177,300,000 | 179,300,000 | 178,700,000 | 184,500,000 | 182,100,000 | 174,400,000 | 159,600,000 | 154,100,000 | 137,000,000 | 123,500,000 | 117,500,000 | 109,900,000 | 261,100,000 | 259,700,000 | 258,300,000 | 260,800,000 | 265,000,000 | 272,600,000 | 275,600,000 | 279,500,000 | 282,100,000 | 286,000,000 | 281,800,000 | 277,800,000 | 292,800,000 |
operating lease right-of-use assets | 27,600,000 | 29,900,000 | 31,100,000 | 32,100,000 | 34,100,000 | 26,500,000 | 29,400,000 | 24,200,000 | 26,800,000 | 27,100,000 | 29,100,000 | 28,300,000 | 30,600,000 | 32,500,000 | 33,900,000 | 36,100,000 | 38,600,000 | 41,400,000 | 42,900,000 | 45,100,000 | 56,500,000 | 60,000,000 | 59,900,000 | 64,000,000 | 67,200,000 | 54,900,000 | ||||||||||||||||||||
goodwill | 394,900,000 | 394,400,000 | 381,200,000 | 455,900,000 | 455,600,000 | 795,100,000 | 794,400,000 | 794,900,000 | 796,100,000 | 791,500,000 | 762,600,000 | 821,500,000 | 819,400,000 | 823,600,000 | 825,000,000 | 826,000,000 | 801,600,000 | 801,800,000 | 802,600,000 | 802,100,000 | 802,500,000 | 801,200,000 | 800,200,000 | 799,800,000 | 800,900,000 | 800,500,000 | 782,300,000 | 783,700,000 | 783,600,000 | 786,700,000 | 763,800,000 | 764,600,000 | 764,700,000 | 1,032,000,000 | 1,030,900,000 | 1,029,700,000 | 1,029,000,000 | 1,031,900,000 | 1,031,600,000 | 946,800,000 | 945,200,000 | 943,400,000 | 1,422,800,000 | 1,422,100,000 | 1,426,100,000 | 1,429,000,000 |
other intangible assets | 117,800,000 | 122,000,000 | 105,400,000 | 107,200,000 | 112,300,000 | 220,100,000 | 226,200,000 | 232,800,000 | 239,500,000 | 242,200,000 | 222,600,000 | 244,700,000 | 251,000,000 | 258,700,000 | 264,900,000 | 271,100,000 | 141,200,000 | 145,300,000 | 149,500,000 | 153,600,000 | 157,700,000 | 170,100,000 | 174,600,000 | 179,300,000 | 184,300,000 | 189,500,000 | 158,500,000 | 163,200,000 | 168,200,000 | 173,900,000 | 139,500,000 | 144,600,000 | 148,900,000 | 154,800,000 | 159,800,000 | 164,400,000 | 169,800,000 | 176,700,000 | 182,400,000 | 77,400,000 | 82,600,000 | 89,000,000 | 95,400,000 | 101,800,000 | 108,300,000 | 116,300,000 |
deferred tax assets | 33,100,000 | 25,300,000 | 25,300,000 | 25,000,000 | 24,900,000 | 6,600,000 | 6,300,000 | 6,300,000 | 6,500,000 | 4,300,000 | 4,400,000 | 4,500,000 | 4,600,000 | 10,900,000 | 11,100,000 | 11,300,000 | 10,000,000 | 23,600,000 | 61,900,000 | 15,400,000 | 10,000,000 | 12,000,000 | 14,000,000 | 11,000,000 | 16,100,000 | 12,300,000 | 13,300,000 | 6,200,000 | 6,300,000 | 6,300,000 | 10,600,000 | 11,300,000 | 7,600,000 | 16,300,000 | 16,100,000 | 15,800,000 | 15,100,000 | 12,200,000 | 12,000,000 | 11,300,000 | 14,900,000 | |||||
other assets | 31,500,000 | 29,300,000 | 25,700,000 | 25,400,000 | 23,200,000 | 25,800,000 | 16,700,000 | 19,100,000 | 19,300,000 | 18,400,000 | 18,500,000 | 18,600,000 | 17,600,000 | 16,100,000 | 16,500,000 | 15,900,000 | 16,500,000 | 11,100,000 | 11,000,000 | 11,300,000 | 11,800,000 | 14,400,000 | 10,700,000 | 10,900,000 | 11,300,000 | 12,800,000 | 15,200,000 | 6,400,000 | 7,600,000 | 3,400,000 | 3,500,000 | 3,800,000 | 4,100,000 | 3,700,000 | 3,600,000 | 3,800,000 | 3,600,000 | 3,600,000 | 3,700,000 | 2,000,000 | 2,000,000 | 25,800,000 | 28,200,000 | 27,600,000 | 27,900,000 | 15,200,000 |
total assets | 1,073,700,000 | 1,067,700,000 | 1,039,000,000 | 1,107,800,000 | 1,154,200,000 | 1,656,200,000 | 1,657,800,000 | 1,661,300,000 | 1,692,400,000 | 1,724,900,000 | 1,666,700,000 | 1,734,900,000 | 1,786,900,000 | 1,775,200,000 | 1,752,800,000 | 1,766,500,000 | 1,594,600,000 | 1,597,900,000 | 1,683,300,000 | 1,648,800,000 | 1,672,800,000 | 1,799,100,000 | 1,755,900,000 | 1,763,700,000 | 1,799,600,000 | 1,807,700,000 | 1,783,400,000 | 1,834,000,000 | 1,833,400,000 | 1,844,500,000 | 1,917,400,000 | 2,202,900,000 | 2,195,900,000 | 2,148,900,000 | 2,124,900,000 | 2,086,400,000 | 2,071,800,000 | 2,095,000,000 | 2,112,000,000 | 2,019,700,000 | 2,000,200,000 | 2,006,300,000 | 2,485,500,000 | 2,536,400,000 | 2,527,600,000 | 2,449,400,000 |
liabilities and stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||||
current liabilities | ||||||||||||||||||||||||||||||||||||||||||||||
current portion of long-term debt | 10,200,000 | 9,400,000 | 9,400,000 | 9,400,000 | 9,400,000 | 9,400,000 | 10,200,000 | 9,400,000 | 8,600,000 | 6,200,000 | 6,200,000 | 6,200,000 | 6,200,000 | 6,200,000 | 4,700,000 | 39,800,000 | ||||||||||||||||||||||||||||||
current portion of operating lease liabilities | 8,200,000 | 9,500,000 | 10,400,000 | 10,400,000 | 10,900,000 | 13,700,000 | 14,400,000 | 11,500,000 | 12,800,000 | 12,700,000 | 13,500,000 | 12,100,000 | 12,800,000 | 13,400,000 | 13,500,000 | 14,500,000 | 14,700,000 | 14,700,000 | 14,900,000 | 15,100,000 | 15,600,000 | 15,400,000 | 14,300,000 | 14,500,000 | 14,700,000 | 11,700,000 | ||||||||||||||||||||
trade accounts payable | 55,500,000 | 54,200,000 | 48,800,000 | 46,000,000 | 54,300,000 | 54,200,000 | 51,400,000 | 57,000,000 | 56,300,000 | 52,100,000 | 65,400,000 | 59,600,000 | 67,900,000 | 62,700,000 | 64,200,000 | 63,800,000 | 56,400,000 | 54,900,000 | 65,500,000 | 59,200,000 | 67,600,000 | 75,900,000 | 75,800,000 | 73,500,000 | 83,000,000 | 94,700,000 | 99,400,000 | 148,800,000 | 169,900,000 | 159,200,000 | 176,900,000 | 194,400,000 | 171,200,000 | 172,500,000 | 184,400,000 | 179,700,000 | 173,100,000 | 166,500,000 | 168,600,000 | 181,100,000 | 163,200,000 | 179,100,000 | 200,600,000 | 192,100,000 | 168,700,000 | 118,400,000 |
accrued expenses | 91,300,000 | 74,800,000 | 66,000,000 | 71,400,000 | 91,300,000 | 82,700,000 | 79,500,000 | 75,100,000 | 93,200,000 | 97,200,000 | 72,700,000 | 80,600,000 | 98,900,000 | 80,000,000 | 68,700,000 | 74,600,000 | 68,100,000 | 59,600,000 | 77,900,000 | 80,300,000 | 83,200,000 | 87,900,000 | 84,800,000 | 101,600,000 | 114,800,000 | 108,900,000 | 72,900,000 | 77,900,000 | 94,400,000 | 106,300,000 | 175,900,000 | 128,300,000 | 144,900,000 | 146,900,000 | 137,400,000 | 130,300,000 | 151,300,000 | 144,200,000 | 136,300,000 | 128,200,000 | 152,000,000 | 147,700,000 | 123,400,000 | 145,000,000 | 183,400,000 | 148,600,000 |
total current liabilities | 165,200,000 | 147,900,000 | 134,600,000 | 137,200,000 | 165,900,000 | 212,900,000 | 208,200,000 | 205,200,000 | 234,600,000 | 170,700,000 | 160,500,000 | 158,500,000 | 185,800,000 | 162,300,000 | 151,100,000 | 152,900,000 | 139,200,000 | 129,200,000 | 158,300,000 | 154,600,000 | 166,300,000 | 179,400,000 | 176,000,000 | 189,400,000 | 212,500,000 | 218,100,000 | 187,000,000 | 238,400,000 | 264,300,000 | 265,500,000 | 352,800,000 | 360,600,000 | 389,800,000 | 319,400,000 | 321,800,000 | 310,000,000 | 324,400,000 | 310,700,000 | 304,900,000 | 309,300,000 | 315,200,000 | 326,800,000 | 324,000,000 | 341,000,000 | 356,000,000 | 277,900,000 |
long-term debt | 90,300,000 | 93,400,000 | 95,700,000 | 98,000,000 | 125,300,000 | 152,600,000 | 164,900,000 | 167,200,000 | 159,400,000 | 258,300,000 | 203,300,000 | 204,700,000 | 226,300,000 | 247,800,000 | 249,300,000 | 254,400,000 | 130,000,000 | 145,000,000 | 165,000,000 | 175,000,000 | 180,000,000 | 248,500,000 | 248,400,000 | 248,200,000 | 248,100,000 | 247,900,000 | 247,800,000 | 247,900,000 | 247,700,000 | 247,600,000 | 247,400,000 | 542,000,000 | 541,100,000 | 580,400,000 | 579,900,000 | 579,400,000 | 579,000,000 | 589,400,000 | 624,000,000 | 578,500,000 | 578,100,000 | 585,900,000 | 585,800,000 | 631,400,000 | 632,300,000 | |
operating lease liabilities | 20,400,000 | 21,400,000 | 21,800,000 | 23,100,000 | 24,600,000 | 26,500,000 | 28,800,000 | 26,600,000 | 28,300,000 | 29,500,000 | 30,900,000 | 32,400,000 | 34,700,000 | 36,800,000 | 38,400,000 | 40,000,000 | 42,800,000 | 46,100,000 | 47,500,000 | 50,100,000 | 56,100,000 | 58,900,000 | 58,800,000 | 62,500,000 | 65,500,000 | 57,700,000 | ||||||||||||||||||||
deferred tax liabilities | 6,100,000 | 6,300,000 | 6,300,000 | 5,600,000 | 5,500,000 | 23,900,000 | 23,400,000 | 23,600,000 | 23,800,000 | 28,700,000 | 21,800,000 | 25,100,000 | 25,400,000 | 37,000,000 | 34,700,000 | 34,700,000 | 9,600,000 | 5,600,000 | 5,600,000 | 5,600,000 | 5,700,000 | 13,800,000 | 500,000 | 600,000 | 4,400,000 | 4,400,000 | 1,100,000 | 1,000,000 | 18,300,000 | 17,800,000 | 36,500,000 | 36,400,000 | 36,200,000 | 35,800,000 | 63,400,000 | 63,400,000 | 23,900,000 | 23,800,000 | ||||||||
other long-term liabilities | 13,500,000 | 20,700,000 | 4,300,000 | 4,500,000 | 4,400,000 | 10,600,000 | 10,500,000 | 10,800,000 | 10,000,000 | 15,600,000 | 15,400,000 | 15,500,000 | 23,500,000 | 27,800,000 | 27,700,000 | 28,000,000 | 9,100,000 | 10,100,000 | 10,600,000 | 10,900,000 | 11,000,000 | 11,400,000 | 11,000,000 | 10,800,000 | 11,200,000 | 11,800,000 | 5,600,000 | 5,500,000 | 19,800,000 | 30,100,000 | 29,600,000 | 30,200,000 | 31,800,000 | 31,900,000 | 30,000,000 | 29,900,000 | 30,100,000 | 30,000,000 | 30,200,000 | 28,200,000 | 27,800,000 | 52,600,000 | 53,900,000 | 52,200,000 | 48,100,000 | |
total liabilities | 295,500,000 | 289,700,000 | 262,700,000 | 268,400,000 | 325,700,000 | 426,500,000 | 435,800,000 | 433,400,000 | 456,100,000 | 502,800,000 | 431,900,000 | 436,200,000 | 495,700,000 | 511,700,000 | 501,200,000 | 510,000,000 | 330,700,000 | 336,000,000 | 387,000,000 | 396,200,000 | 416,300,000 | 509,200,000 | 494,300,000 | 507,200,000 | 534,400,000 | 540,800,000 | 506,500,000 | 553,900,000 | 536,200,000 | 544,300,000 | 630,800,000 | 951,100,000 | 980,500,000 | 968,200,000 | 968,100,000 | 955,500,000 | 969,300,000 | 993,500,000 | 1,022,500,000 | 939,900,000 | 944,900,000 | 965,300,000 | 963,700,000 | 1,024,600,000 | 1,036,400,000 | 370,400,000 |
commitments and contingencies | ||||||||||||||||||||||||||||||||||||||||||||||
stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par value - authorized 20,000,000 shares, none issued | ||||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,456,462 outstanding at december 31, 2025 and 45,962,627 outstanding at december 31, 2024 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
additional paid-in capital | 1,691,900,000 | 1,690,700,000 | 1,686,900,000 | 1,682,800,000 | 1,678,600,000 | 1,674,700,000 | 1,671,500,000 | 1,667,700,000 | 1,663,600,000 | 1,659,700,000 | 1,654,900,000 | 1,651,000,000 | 1,646,400,000 | 1,642,300,000 | 1,637,400,000 | 1,633,300,000 | 1,628,800,000 | 1,625,700,000 | 1,621,300,000 | 1,617,300,000 | 1,609,400,000 | 1,604,100,000 | 1,599,900,000 | 1,596,400,000 | 1,593,900,000 | 1,592,100,000 | 1,586,800,000 | 1,582,500,000 | 1,578,100,000 | 1,575,500,000 | 1,567,700,000 | 1,557,300,000 | 1,550,500,000 | 1,547,400,000 | 1,543,800,000 | 1,538,100,000 | 1,533,200,000 | 1,530,400,000 | 1,527,300,000 | 1,521,700,000 | 1,518,000,000 | 1,517,900,000 | 1,514,300,000 | 1,507,900,000 | 1,502,500,000 | |
accumulated deficit | -779,900,000 | -778,600,000 | -777,200,000 | -700,400,000 | -707,000,000 | -309,700,000 | -314,000,000 | -315,800,000 | -314,900,000 | -325,400,000 | -321,700,000 | -253,600,000 | -253,100,000 | -270,000,000 | -293,100,000 | -304,500,000 | -310,300,000 | -320,300,000 | -285,200,000 | -323,100,000 | -315,500,000 | -268,300,000 | -287,600,000 | -284,600,000 | -288,300,000 | -282,200,000 | -270,700,000 | -262,700,000 | -242,400,000 | -240,200,000 | -244,400,000 | -279,700,000 | -299,900,000 | -332,700,000 | -349,300,000 | -366,400,000 | -379,200,000 | -389,200,000 | -398,300,000 | -404,800,000 | ||||||
treasury stock | -102,300,000 | -102,000,000 | -101,900,000 | -101,200,000 | -99,000,000 | -98,900,000 | -98,500,000 | -95,000,000 | -85,900,000 | -79,700,000 | -70,500,000 | -67,900,000 | -66,800,000 | -66,400,000 | -55,400,000 | -40,700,000 | -21,300,000 | -10,400,000 | -10,300,000 | -9,800,000 | -9,800,000 | -9,300,000 | -9,200,000 | -8,900,000 | -8,900,000 | -8,700,000 | -8,600,000 | -7,200,000 | -5,300,000 | -5,100,000 | -5,100,000 | -4,500,000 | -4,400,000 | -3,900,000 | -3,900,000 | -1,900,000 | -1,900,000 | -1,900,000 | -1,900,000 | -1,000,000 | -1,000,000 | -1,000,000 | -1,000,000 | |||
accumulated other comprehensive loss | -32,000,000 | -32,600,000 | -32,000,000 | -42,300,000 | -44,600,000 | -36,900,000 | -37,500,000 | -29,500,000 | -27,000,000 | -33,000,000 | -28,400,000 | -31,300,000 | -35,800,000 | -42,900,000 | -37,800,000 | -32,100,000 | -33,800,000 | -33,600,000 | -30,000,000 | -32,300,000 | -28,100,000 | -37,100,000 | -42,000,000 | -46,900,000 | -32,000,000 | -34,800,000 | -31,100,000 | -33,000,000 | -33,700,000 | -30,500,000 | -32,100,000 | -21,800,000 | -31,300,000 | -30,600,000 | -34,300,000 | -39,400,000 | -50,100,000 | -38,300,000 | -38,100,000 | -36,600,000 | -43,200,000 | -42,800,000 | -28,900,000 | -25,600,000 | -21,100,000 | |
total stockholders’ equity | 778,200,000 | 778,000,000 | 776,300,000 | 839,400,000 | 828,500,000 | 1,229,700,000 | 1,222,000,000 | 1,227,900,000 | 1,236,300,000 | 1,222,100,000 | 1,234,800,000 | 1,298,700,000 | 1,291,200,000 | 1,263,500,000 | 1,251,600,000 | 1,256,500,000 | 1,263,900,000 | 1,261,900,000 | 1,296,300,000 | 1,252,600,000 | 1,256,500,000 | 1,289,900,000 | 1,261,600,000 | 1,256,500,000 | 1,265,200,000 | 1,266,900,000 | 1,276,900,000 | 1,280,100,000 | 1,297,200,000 | 1,300,200,000 | 1,286,600,000 | 1,251,800,000 | 1,215,400,000 | 1,180,700,000 | 1,156,800,000 | 1,130,900,000 | 1,102,500,000 | 1,101,500,000 | 1,089,500,000 | 1,079,800,000 | 1,055,300,000 | 1,041,000,000 | 1,521,800,000 | 1,511,800,000 | 1,491,200,000 | |
total liabilities and stockholders’ equity | 1,073,700,000 | 1,067,700,000 | 1,039,000,000 | 1,107,800,000 | 1,154,200,000 | 1,656,200,000 | 1,657,800,000 | 1,661,300,000 | 1,692,400,000 | 1,724,900,000 | 1,666,700,000 | 1,734,900,000 | 1,786,900,000 | 1,775,200,000 | 1,752,800,000 | 1,766,500,000 | 1,594,600,000 | 1,597,900,000 | 1,683,300,000 | 1,648,800,000 | 1,672,800,000 | 1,799,100,000 | 1,755,900,000 | 1,763,700,000 | 1,799,600,000 | 1,807,700,000 | 1,783,400,000 | 1,834,000,000 | 1,833,400,000 | 1,844,500,000 | 1,917,400,000 | 2,202,900,000 | 2,195,900,000 | 2,148,900,000 | 2,124,900,000 | 2,086,400,000 | 2,071,800,000 | 2,095,000,000 | 2,112,000,000 | 2,019,700,000 | 2,000,200,000 | 2,006,300,000 | 2,485,500,000 | 2,536,400,000 | 2,527,600,000 | |
common stock - 0.01 par value - authorized 300,000,000 shares, 46,416,998 outstanding as of september 30, 2025 and 45,962,627 outstanding as of december 31, 2024 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,314,057 outstanding as of june 30, 2025 and 45,962,627 outstanding as of december 31, 2024 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,236,444 outstanding as of march 31, 2025 and 45,962,627 outstanding as of december 31, 2024 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
assets held for sale | 73,900,000 | 72,700,000 | 66,500,000 | 64,500,000 | 102,100,000 | 108,700,000 | 650,400,000 | 632,500,000 | 2,600,000 | |||||||||||||||||||||||||||||||||||||
liabilities held for sale | 52,900,000 | 52,700,000 | 52,200,000 | 63,700,000 | 2,500,000 | 2,700,000 | 37,900,000 | 33,900,000 | ||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 45,962,627 outstanding at december 31, 2024 and 46,174,337 outstanding at december 31, 2023 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 45,954,931 outstanding as of september 30, 2024 and 46,174,337 outstanding as of december 31, 2023 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 45,913,043 outstanding as of june 30, 2024 and 46,174,337 outstanding as of december 31, 2023 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,066,997 outstanding as of march 31, 2024 and 46,174,337 outstanding as of december 31, 2023 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,174,337 outstanding at december 31, 2023 and 46,528,907 outstanding at december 31, 2022 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,425,157 outstanding as of september 30, 2023 and 46,528,907 outstanding as of december 31, 2022 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,832,847 outstanding as of june 30, 2023 and 46,528,907 outstanding as of december 31, 2022 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,660,199 outstanding as of march 31, 2023 and 46,528,907 outstanding as of december 31, 2022 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,528,907 outstanding at december 31, 2022 and 48,206,156 outstanding at december 31, 2021 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,495,519 outstanding as of september 30, 2022 and 48,206,156 outstanding as of december 31, 2021 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,849,951 outstanding as of june 30, 2022 and 48,206,156 outstanding as of december 31, 2021 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,324,093 outstanding as of march 31, 2022 and 48,206,156 outstanding as of december 31, 2021 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
income tax receivable | 13,000,000 | 11,600,000 | 58,400,000 | 59,000,000 | 59,300,000 | |||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 48,206,156 outstanding at december 31, 2021 and 47,917,583 outstanding at december 31, 2020 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
prepaid expenses and other current assets | 19,700,000 | 18,800,000 | 18,300,000 | 21,200,000 | 20,200,000 | 23,700,000 | 29,900,000 | 26,200,000 | 47,100,000 | 52,400,000 | 48,400,000 | 15,800,000 | 20,000,000 | 19,700,000 | 16,700,000 | 31,100,000 | 25,000,000 | 26,800,000 | ||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 48,128,749 outstanding as of september 30, 2021 and 47,917,583 outstanding as of december 31, 2020 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 48,095,484 outstanding as of june 30, 2021 and 47,917,583 outstanding as of december 31, 2020 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 48,059,819 outstanding as of march 31, 2021 and 47,917,583 outstanding as of december 31, 2020 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
operating lease right of use assets | 48,300,000 | 64,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
current portion of operating lease obligation | 15,500,000 | 14,700,000 | ||||||||||||||||||||||||||||||||||||||||||||
operating lease obligation | 53,300,000 | 62,600,000 | ||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,917,583 outstanding at december 31, 2020 and 47,734,206 outstanding at december 31, 2019 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,833,115 outstanding as of september 30, 2020 and 47,734,206 outstanding as of december 31, 2019 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,802,185 outstanding as of june 30, 2020 and 47,734,206 outstanding as of december 31, 2019 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,755,911 outstanding as of march 31, 2020 and 47,734,206 outstanding as of december 31, 2019 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,734,206 outstanding at december 31, 2019 and 47,444,340 outstanding at december 31, 2018 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,719,954 outstanding as of september 30, 2019 and 47,444,340 outstanding as of december 31, 2018 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,653,527 outstanding as of june 30, 2019 and 47,444,340 outstanding as of december 31, 2018 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,504,680 outstanding as of march 31, 2019 and 47,444,340 outstanding as of december 31, 2018 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,444,340 outstanding at december 31, 2018 and 46,920,076 outstanding at december 31, 2017 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,426,996 outstanding as of september 30, 2018 and 46,920,076 outstanding as of december 31, 2017 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
restricted cash | 51,500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,279,645 outstanding as of june 30, 2018 and 46,920,076 outstanding as of december 31, 2017 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 47,014,536 outstanding as of march 31, 2018 and 46,920,076 outstanding as of december 31, 2017 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,920,076 outstanding at december 31, 2017 and 46,681,798 outstanding at december 31, 2016 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,835,044 outstanding as of september 30, 2017 and 46,681,798 outstanding as of december 31, 2016 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,791,748 outstanding at june 30, 2017 and 46,681,798 outstanding at december 31, 2016 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,695,242 outstanding at march 31, 2017 and 46,681,798 outstanding at december 31, 2016 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,681,798 outstanding at december 31, 2016 and 46,614,947 outstanding at december 31, 2015 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,674,183 outstanding at september 30, 2016 and 46,614,947 outstanding at december 31, 2015 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,670,129 outstanding at june 30, 2016 and 46,614,947 outstanding at december 31, 2015 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,614,947 outstanding at march 31, 2016 and december 31, 2015 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
current deferred income taxes | 2,100,000 | |||||||||||||||||||||||||||||||||||||||||||||
debt payable within one year | 3,900,000 | 3,900,000 | 10,900,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,614,947 outstanding at december 31, 2015 and 46,535,951 outstanding at december 31, 2014 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
(accumulated deficit) retained earnings | -419,000,000 | -433,600,000 | ||||||||||||||||||||||||||||||||||||||||||||
current deferred income taxes and other current assets | 25,500,000 | 14,800,000 | 17,400,000 | 50,800,000 | ||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,613,982 outstanding as of september 30, 2015 and 46,535,951 as of december 31, 2014 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,605,790 outstanding as of june 30, 2015 and 46,535,951 as of december 31, 2014 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
retained earnings | 36,900,000 | 29,000,000 | 7,300,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,535,951 outstanding as of march 31, 2015 and december 31, 2014 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
liabilities and equity | ||||||||||||||||||||||||||||||||||||||||||||||
related party debt | ||||||||||||||||||||||||||||||||||||||||||||||
preferred stock—0.01 par value—authorized 20,000,000 shares, none issued | ||||||||||||||||||||||||||||||||||||||||||||||
common stock—0.01 par value—authorized 300,000,000 shares in 2014; 46,535,951 outstanding at december 31, 2014 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||
kimberly-clark’s net investment | ||||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive income | -19,100,000 | |||||||||||||||||||||||||||||||||||||||||||||
liabilities and invested equity | ||||||||||||||||||||||||||||||||||||||||||||||
long-term liabilities | 92,500,000 | |||||||||||||||||||||||||||||||||||||||||||||
invested equity | ||||||||||||||||||||||||||||||||||||||||||||||
kimberly-clark's net investment | 2,100,100,000 | |||||||||||||||||||||||||||||||||||||||||||||
total invested equity | 2,079,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
total liabilities and invested equity | 2,449,400,000 | |||||||||||||||||||||||||||||||||||||||||||||
operating activities | ||||||||||||||||||||||||||||||||||||||||||||||
net income | 29,500,000 | |||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization | 61,600,000 | |||||||||||||||||||||||||||||||||||||||||||||
share-based compensation charged by kimberly-clark | 5,100,000 | |||||||||||||||||||||||||||||||||||||||||||||
benefit from losses on accounts receivable and inventories | 100,000 | |||||||||||||||||||||||||||||||||||||||||||||
deferred income taxes | -13,900,000 | |||||||||||||||||||||||||||||||||||||||||||||
asset impairment | 41,900,000 | |||||||||||||||||||||||||||||||||||||||||||||
net incomees on asset dispositions | 3,500,000 | |||||||||||||||||||||||||||||||||||||||||||||
changes in operating working capital: | ||||||||||||||||||||||||||||||||||||||||||||||
decrease (increase) in accounts receivable | 10,900,000 | |||||||||||||||||||||||||||||||||||||||||||||
increase in inventories | -9,100,000 | |||||||||||||||||||||||||||||||||||||||||||||
increase in trade accounts payable | 7,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
decrease in accrued expenses | -23,600,000 | |||||||||||||||||||||||||||||||||||||||||||||
decrease in accrued income taxes | -3,900,000 | |||||||||||||||||||||||||||||||||||||||||||||
other | -1,800,000 | |||||||||||||||||||||||||||||||||||||||||||||
cash from operating activities | 107,300,000 | |||||||||||||||||||||||||||||||||||||||||||||
investing activities | ||||||||||||||||||||||||||||||||||||||||||||||
capital spending | -60,400,000 | |||||||||||||||||||||||||||||||||||||||||||||
cash outflows for acquisitions and investments | ||||||||||||||||||||||||||||||||||||||||||||||
cash from investing activities | -60,400,000 | |||||||||||||||||||||||||||||||||||||||||||||
financing activities | ||||||||||||||||||||||||||||||||||||||||||||||
debt proceeds | 1,900,000 | |||||||||||||||||||||||||||||||||||||||||||||
debt repayments | -2,900,000 | |||||||||||||||||||||||||||||||||||||||||||||
change in kimberly-clark's net investment | -34,800,000 | |||||||||||||||||||||||||||||||||||||||||||||
cash from financing activities | -32,400,000 | |||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rate changes on cash and cash equivalents | -200,000 | |||||||||||||||||||||||||||||||||||||||||||||
increase in cash and cash equivalents | 14,300,000 | |||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents - beginning of period | 44,100,000 | |||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents - end of period | 58,400,000 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net sales | ||||||||||||||||||||||||||||||||||||||||||||
cost of products sold | ||||||||||||||||||||||||||||||||||||||||||||
gross profit | ||||||||||||||||||||||||||||||||||||||||||||
research and development | ||||||||||||||||||||||||||||||||||||||||||||
selling and general expenses | ||||||||||||||||||||||||||||||||||||||||||||
other income | ||||||||||||||||||||||||||||||||||||||||||||
operating income | ||||||||||||||||||||||||||||||||||||||||||||
interest income | ||||||||||||||||||||||||||||||||||||||||||||
interest expense | ||||||||||||||||||||||||||||||||||||||||||||
income before income taxes | ||||||||||||||||||||||||||||||||||||||||||||
income tax benefit | ||||||||||||||||||||||||||||||||||||||||||||
net income | -1,400,000 | -76,800,000 | 6,600,000 | -397,300,000 | 4,300,000 | 1,800,000 | -900,000 | 10,500,000 | -3,700,000 | -68,100,000 | -500,000 | 16,900,000 | 16,400,000 | 11,400,000 | 5,800,000 | 10,000,000 | -35,100,000 | 37,900,000 | -7,600,000 | -47,200,000 | 19,300,000 | -3,000,000 | 3,700,000 | 12,800,000 | 21,700,000 | |||||||||||||||||||
earnings per share | ||||||||||||||||||||||||||||||||||||||||||||
basic | ||||||||||||||||||||||||||||||||||||||||||||
diluted | ||||||||||||||||||||||||||||||||||||||||||||
table of contents | ||||||||||||||||||||||||||||||||||||||||||||
other comprehensive income, net of tax | ||||||||||||||||||||||||||||||||||||||||||||
unrealized currency translation adjustments | 9,800,000 | |||||||||||||||||||||||||||||||||||||||||||
comprehensive income | 23,500,000 | |||||||||||||||||||||||||||||||||||||||||||
assets | ||||||||||||||||||||||||||||||||||||||||||||
current assets | ||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | 143,100,000 | |||||||||||||||||||||||||||||||||||||||||||
accounts receivable, net of allowances | 181,200,000 | |||||||||||||||||||||||||||||||||||||||||||
inventories | -500,000 | -3,300,000 | 1,200,000 | 1,900,000 | -3,100,000 | -4,700,000 | 6,500,000 | -4,500,000 | -8,600,000 | -18,700,000 | -12,600,000 | -4,500,000 | 700,000 | 5,900,000 | 2,800,000 | -9,400,000 | -20,600,000 | -8,500,000 | 273,400,000 | -9,900,000 | ||||||||||||||||||||||||
prepaid and other current assets | ||||||||||||||||||||||||||||||||||||||||||||
total current assets | 614,400,000 | |||||||||||||||||||||||||||||||||||||||||||
property, plant and equipment | 258,300,000 | |||||||||||||||||||||||||||||||||||||||||||
operating lease right-of-use assets | ||||||||||||||||||||||||||||||||||||||||||||
goodwill | 1,029,700,000 | |||||||||||||||||||||||||||||||||||||||||||
other intangible assets | 164,400,000 | |||||||||||||||||||||||||||||||||||||||||||
deferred tax assets | 15,800,000 | |||||||||||||||||||||||||||||||||||||||||||
other assets | 3,800,000 | |||||||||||||||||||||||||||||||||||||||||||
total assets | 2,086,400,000 | |||||||||||||||||||||||||||||||||||||||||||
liabilities and stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||
current liabilities | ||||||||||||||||||||||||||||||||||||||||||||
current portion of long-term debt | ||||||||||||||||||||||||||||||||||||||||||||
current portion of operating lease liabilities | ||||||||||||||||||||||||||||||||||||||||||||
trade accounts payable | 179,700,000 | |||||||||||||||||||||||||||||||||||||||||||
accrued expenses | -400,000 | -7,200,000 | -14,800,000 | -7,700,000 | 7,000,000 | 16,900,000 | -27,600,000 | -8,000,000 | 17,400,000 | -9,600,000 | -27,500,000 | 11,400,000 | 10,200,000 | -100,000 | -28,600,000 | 57,800,000 | -18,800,000 | -3,600,000 | -2,000,000 | -51,600,000 | 6,700,000 | -14,900,000 | -14,500,000 | 130,300,000 | -26,500,000 | |||||||||||||||||||
total current liabilities | 310,000,000 | |||||||||||||||||||||||||||||||||||||||||||
long-term debt | 579,400,000 | |||||||||||||||||||||||||||||||||||||||||||
operating lease liabilities | ||||||||||||||||||||||||||||||||||||||||||||
deferred tax liabilities | 36,200,000 | |||||||||||||||||||||||||||||||||||||||||||
other long-term liabilities | 29,900,000 | |||||||||||||||||||||||||||||||||||||||||||
total liabilities | 955,500,000 | |||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies | ||||||||||||||||||||||||||||||||||||||||||||
stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par value - authorized 20,000,000 shares, none issued | ||||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,849,951 outstanding as of june 30, 2022 and 48,206,156 outstanding as of december 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||
additional paid-in capital | 1,538,100,000 | |||||||||||||||||||||||||||||||||||||||||||
accumulated deficit | -366,400,000 | |||||||||||||||||||||||||||||||||||||||||||
treasury stock | -1,900,000 | |||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive loss | -39,400,000 | |||||||||||||||||||||||||||||||||||||||||||
total stockholders’ equity | 1,130,900,000 | |||||||||||||||||||||||||||||||||||||||||||
total liabilities and stockholders’ equity | 2,086,400,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock | ||||||||||||||||||||||||||||||||||||||||||||
additional paid-in capital, beginning of period | ||||||||||||||||||||||||||||||||||||||||||||
exercise or redemption of share-based awards | ||||||||||||||||||||||||||||||||||||||||||||
stock-based compensation expense | 3,500,000 | 4,100,000 | 3,800,000 | 2,600,000 | 3,800,000 | 3,600,000 | 3,900,000 | 3,900,000 | 4,000,000 | 4,100,000 | 4,000,000 | 3,800,000 | 3,500,000 | 3,600,000 | 3,100,000 | 3,400,000 | 3,000,000 | 2,500,000 | 4,400,000 | 5,400,000 | ||||||||||||||||||||||||
additional paid-in capital, end of period | ||||||||||||||||||||||||||||||||||||||||||||
accumulated deficit, beginning of period | ||||||||||||||||||||||||||||||||||||||||||||
accumulated deficit, end of period | ||||||||||||||||||||||||||||||||||||||||||||
treasury stock, beginning of period | ||||||||||||||||||||||||||||||||||||||||||||
purchases of treasury stock | 0 | -800,000 | -2,200,000 | -100,000 | -3,500,000 | -9,100,000 | -9,200,000 | -2,600,000 | -1,100,000 | -11,000,000 | -14,700,000 | -19,400,000 | -100,000 | -100,000 | -100,000 | |||||||||||||||||||||||||||||
treasury stock, end of period | ||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive income, beginning of period | ||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive income, end of period | ||||||||||||||||||||||||||||||||||||||||||||
total stockholders’ equity, end of period | ||||||||||||||||||||||||||||||||||||||||||||
operating activities | ||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization | 9,400,000 | 10,000,000 | 9,600,000 | 11,100,000 | 11,700,000 | 11,300,000 | 11,400,000 | 11,500,000 | 11,000,000 | 11,500,000 | 12,100,000 | 13,400,000 | 11,600,000 | 11,600,000 | 11,100,000 | 9,500,000 | 9,600,000 | 9,500,000 | 9,700,000 | 10,800,000 | 10,700,000 | 10,800,000 | 10,600,000 | 16,200,000 | 16,400,000 | 23,800,000 | ||||||||||||||||||
net income on asset dispositions and impairments | 200,000 | 100,000 | 0 | 300,000 | 0 | |||||||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities, net of acquisition: | ||||||||||||||||||||||||||||||||||||||||||||
accounts receivable | 700,000 | -3,000,000 | 25,100,000 | 300,000 | -7,700,000 | -7,400,000 | 8,200,000 | 9,000,000 | 11,100,000 | -7,300,000 | 26,200,000 | -18,700,000 | 900,000 | 8,800,000 | -15,700,000 | -300,000 | -11,800,000 | -900,000 | 2,200,000 | 11,500,000 | -3,600,000 | 20,900,000 | 17,000,000 | 8,100,000 | 7,500,000 | |||||||||||||||||||
prepaid expenses and other assets | -3,800,000 | 1,900,000 | 300,000 | 7,200,000 | 3,700,000 | 4,200,000 | -200,000 | -19,800,000 | -200,000 | 1,900,000 | -1,500,000 | -500,000 | 2,900,000 | 500,000 | 100,000 | -3,000,000 | -200,000 | 800,000 | 500,000 | 1,000,000 | -900,000 | 3,300,000 | -2,000,000 | 1,300,000 | 1,300,000 | |||||||||||||||||||
accounts payable | 1,100,000 | 4,800,000 | -6,400,000 | 300,000 | 2,300,000 | 1,600,000 | -14,200,000 | 6,100,000 | -7,900,000 | 1,300,000 | 600,000 | 3,300,000 | 30,200,000 | 0 | -9,700,000 | 4,000,000 | -6,200,000 | -10,800,000 | -2,400,000 | 2,500,000 | -8,200,000 | 11,200,000 | 36,500,000 | |||||||||||||||||||||
deferred income taxes and other | 0 | -800,000 | 100,000 | -42,200,000 | 600,000 | 2,600,000 | -400,000 | -19,900,000 | -3,800,000 | 4,400,000 | -3,100,000 | 400,000 | 100,000 | -400,000 | 11,900,000 | 37,300,000 | -46,700,000 | -5,900,000 | 45,100,000 | -23,800,000 | -1,100,000 | -6,400,000 | ||||||||||||||||||||||
cash from operating activities | 14,000,000 | 6,800,000 | 25,700,000 | 57,900,000 | 23,000,000 | 27,800,000 | -8,000,000 | 12,700,000 | 29,100,000 | -2,600,000 | -6,800,000 | 33,700,000 | 28,400,000 | 27,000,000 | 1,800,000 | 52,100,000 | 23,200,000 | 15,300,000 | -3,300,000 | 1,100,000 | 1,100,000 | 1,100,000 | -5,800,000 | 53,100,000 | 3,900,000 | -14,900,000 | -12,800,000 | 64,200,000 | -25,100,000 | -89,800,000 | -24,400,000 | -37,200,000 | 1,400,000 | -44,500,000 | 37,000,000 | -26,900,000 | 1,400,000 | 7,700,000 | -15,200,000 | -16,800,000 | -9,000,000 | -58,600,000 | 39,700,000 | 40,600,000 |
investing activities | ||||||||||||||||||||||||||||||||||||||||||||
capital expenditures | -7,000,000 | -11,000,000 | -6,700,000 | -4,800,000 | -3,000,000 | -5,900,000 | -4,100,000 | -5,900,000 | -3,900,000 | -4,000,000 | -4,000,000 | -4,900,000 | -5,300,000 | -4,100,000 | -5,000,000 | -4,700,000 | -4,800,000 | -5,800,000 | -5,700,000 | -5,100,000 | -3,000,000 | -6,900,000 | -5,200,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10,200,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -27,700,000 | 0 |
free cash flows | 7,000,000 | -4,200,000 | 19,000,000 | 53,100,000 | 20,000,000 | 21,900,000 | -12,100,000 | 6,800,000 | 25,200,000 | -6,600,000 | -10,800,000 | 28,800,000 | 23,100,000 | 22,900,000 | -3,200,000 | 47,400,000 | 18,400,000 | 9,500,000 | -9,000,000 | -4,000,000 | -1,900,000 | -5,800,000 | -11,000,000 | 53,100,000 | 3,900,000 | -14,900,000 | -12,800,000 | 64,200,000 | -25,100,000 | -89,800,000 | -24,400,000 | -37,200,000 | 1,400,000 | -44,500,000 | 26,800,000 | -26,900,000 | 1,400,000 | 7,700,000 | -15,200,000 | -16,800,000 | -9,000,000 | -58,600,000 | 12,000,000 | 40,600,000 |
acquisition of assets and investments in businesses | -45,000,000 | 600,000 | 0 | -116,700,000 | ||||||||||||||||||||||||||||||||||||||||
cash from investing activities | -31,500,000 | -13,200,000 | -9,100,000 | -7,600,000 | -12,000,000 | -5,900,000 | -2,000,000 | 81,000,000 | -48,900,000 | -6,500,000 | -4,000,000 | -4,700,000 | -4,100,000 | -121,700,000 | -4,700,000 | -4,800,000 | -5,800,000 | -5,700,000 | -5,100,000 | -7,000,000 | -6,900,000 | -5,200,000 | 0 | -50,500,000 | -100,000 | -47,200,000 | 100,000 | -164,400,000 | -10,200,000 | 0 | 100,000 | -20,000,000 | -10,300,000 | |||||||||||
financing activities | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of secured debt | 0 | 0 | 125,000,000 | 125,000,000 | ||||||||||||||||||||||||||||||||||||||||
secured debt repayments | -2,300,000 | -2,400,000 | -2,300,000 | -2,300,000 | -3,200,000 | -1,500,000 | -1,600,000 | -1,600,000 | 0 | -1,500,000 | -1,600,000 | -1,600,000 | 0 | |||||||||||||||||||||||||||||||
revolving credit facility proceeds | 0 | 0 | 0 | 20,000,000 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||
revolving credit facility repayments | 0 | 0 | -25,000,000 | -25,000,000 | -10,000,000 | 0 | -10,000,000 | -95,000,000 | 0 | 0 | -20,000,000 | -20,000,000 | 0 | -40,000,000 | -10,000,000 | -5,000,000 | ||||||||||||||||||||||||||||
payments of debt issuance costs | 0 | -2,300,000 | -600,000 | |||||||||||||||||||||||||||||||||||||||||
proceeds from the exercise of stock options | 300,000 | 0 | 400,000 | 0 | 600,000 | 0 | 500,000 | -200,000 | 900,000 | 0 | 600,000 | 100,000 | 800,000 | 100,000 | 700,000 | 100,000 | 900,000 | 400,000 | 4,800,000 | 2,000,000 | 800,000 | 2,600,000 | 2,400,000 | 200,000 | 5,400,000 | 8,000,000 | 3,400,000 | 500,000 | 300,000 | |||||||||||||||
cash from financing activities | -2,000,000 | -3,200,000 | -29,100,000 | -27,400,000 | -16,000,000 | -5,000,000 | -700,000 | -114,700,000 | 46,700,000 | -4,100,000 | -22,100,000 | -21,900,000 | -10,200,000 | -16,900,000 | 105,700,000 | -25,800,000 | -19,200,000 | -10,100,000 | -200,000 | -68,300,000 | -2,000,000 | -47,900,000 | -38,900,000 | -49,100,000 | -20,900,000 | -87,700,000 | 238,400,000 | -355,500,000 | -5,000,000 | -3,600,000 | 800,000 | 105,900,000 | 500,000 | 62,200,000 | 800,000 | 80,800,000 | 25,600,000 | -10,600,000 | -4,800,000 | 12,300,000 | -1,000,000 | 61,600,000 | ||
effect of exchange rate changes on cash and cash equivalents | -300,000 | 2,900,000 | 1,800,000 | -4,200,000 | 1,800,000 | -500,000 | -1,200,000 | 1,600,000 | -1,600,000 | -700,000 | 900,000 | 3,800,000 | -3,000,000 | -900,000 | -1,300,000 | 400,000 | -2,200,000 | 3,800,000 | 2,900,000 | 2,800,000 | -6,600,000 | 2,100,000 | -1,500,000 | -1,300,000 | ||||||||||||||||||||
decrease in cash and cash equivalents | -10,700,000 | -11,900,000 | 25,300,000 | -13,900,000 | -32,000,000 | 10,500,000 | 2,200,000 | -14,200,000 | -2,100,000 | -200,000 | -11,400,000 | -5,000,000 | -2,700,000 | -17,600,000 | 12,500,000 | -13,800,000 | ||||||||||||||||||||||||||||
cash and cash equivalents - beginning of period | 0 | 0 | 107,700,000 | 0 | 0 | 87,700,000 | 0 | 0 | 127,700,000 | 0 | 0 | 118,500,000 | 0 | 0 | 111,500,000 | 0 | 0 | 205,300,000 | 113,700,000 | 149,000,000 | ||||||||||||||||||||||||
cash and cash equivalents - end of period | -19,800,000 | -6,700,000 | 97,000,000 | -3,200,000 | 16,400,000 | 75,800,000 | 25,300,000 | -13,900,000 | 95,700,000 | 10,500,000 | 2,200,000 | 104,300,000 | -2,100,000 | -200,000 | 100,100,000 | -5,000,000 | -2,700,000 | 187,700,000 | 143,100,000 | 166,200,000 | ||||||||||||||||||||||||
inventory | ||||||||||||||||||||||||||||||||||||||||||||
other current assets | ||||||||||||||||||||||||||||||||||||||||||||
other current liabilities | ||||||||||||||||||||||||||||||||||||||||||||
contingent consideration | ||||||||||||||||||||||||||||||||||||||||||||
other non-current assets | ||||||||||||||||||||||||||||||||||||||||||||
deferred tax liability | ||||||||||||||||||||||||||||||||||||||||||||
identifiable intangible assets | ||||||||||||||||||||||||||||||||||||||||||||
total | ||||||||||||||||||||||||||||||||||||||||||||
trademarks | ||||||||||||||||||||||||||||||||||||||||||||
other | 3,500,000 | -600,000 | -300,000 | |||||||||||||||||||||||||||||||||||||||||
earnings per share: | ||||||||||||||||||||||||||||||||||||||||||||
income tax receivable | ||||||||||||||||||||||||||||||||||||||||||||
allowances and doubtful accounts: | ||||||||||||||||||||||||||||||||||||||||||||
doubtful accounts | ||||||||||||||||||||||||||||||||||||||||||||
sales discounts | ||||||||||||||||||||||||||||||||||||||||||||
raw materials | ||||||||||||||||||||||||||||||||||||||||||||
work in process | ||||||||||||||||||||||||||||||||||||||||||||
finished goods | ||||||||||||||||||||||||||||||||||||||||||||
supplies and other | ||||||||||||||||||||||||||||||||||||||||||||
excess of fifo or weighted-average cost over lifo cost | ||||||||||||||||||||||||||||||||||||||||||||
land | ||||||||||||||||||||||||||||||||||||||||||||
buildings and leasehold improvements | ||||||||||||||||||||||||||||||||||||||||||||
machinery and equipment | ||||||||||||||||||||||||||||||||||||||||||||
construction in progress | ||||||||||||||||||||||||||||||||||||||||||||
less accumulated depreciation | ||||||||||||||||||||||||||||||||||||||||||||
balance, december 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||
goodwill acquired | ||||||||||||||||||||||||||||||||||||||||||||
currency translation adjustment | ||||||||||||||||||||||||||||||||||||||||||||
balance, june 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||
patents and acquired technologies | ||||||||||||||||||||||||||||||||||||||||||||
remainder of 2022 | ||||||||||||||||||||||||||||||||||||||||||||
2023 | ||||||||||||||||||||||||||||||||||||||||||||
2024 | ||||||||||||||||||||||||||||||||||||||||||||
2025 | ||||||||||||||||||||||||||||||||||||||||||||
2026 | ||||||||||||||||||||||||||||||||||||||||||||
thereafter | ||||||||||||||||||||||||||||||||||||||||||||
accrued rebates and customer incentives | ||||||||||||||||||||||||||||||||||||||||||||
accrued salaries and wages | ||||||||||||||||||||||||||||||||||||||||||||
accrued taxes and other | ||||||||||||||||||||||||||||||||||||||||||||
accrued compensation and benefits | ||||||||||||||||||||||||||||||||||||||||||||
liabilities | ||||||||||||||||||||||||||||||||||||||||||||
revolving credit facility | ||||||||||||||||||||||||||||||||||||||||||||
term loan facility | ||||||||||||||||||||||||||||||||||||||||||||
contingent consideration related to acquisition | ||||||||||||||||||||||||||||||||||||||||||||
unamortized debt issuance costs | ||||||||||||||||||||||||||||||||||||||||||||
total long-term debt | ||||||||||||||||||||||||||||||||||||||||||||
unrealized currency translation | ||||||||||||||||||||||||||||||||||||||||||||
other comprehensive income | ||||||||||||||||||||||||||||||||||||||||||||
change in aoci | ||||||||||||||||||||||||||||||||||||||||||||
stock options | ||||||||||||||||||||||||||||||||||||||||||||
time-based restricted share units | ||||||||||||||||||||||||||||||||||||||||||||
performance-based restricted share units | ||||||||||||||||||||||||||||||||||||||||||||
employee stock purchase plan | ||||||||||||||||||||||||||||||||||||||||||||
total stock-based compensation | ||||||||||||||||||||||||||||||||||||||||||||
weighted-average shares outstanding: | ||||||||||||||||||||||||||||||||||||||||||||
basic weighted-average shares outstanding | ||||||||||||||||||||||||||||||||||||||||||||
dilutive effect of stock options and restricted share unit awards | ||||||||||||||||||||||||||||||||||||||||||||
diluted weighted-average shares outstanding | ||||||||||||||||||||||||||||||||||||||||||||
chronic care: | ||||||||||||||||||||||||||||||||||||||||||||
digestive health | ||||||||||||||||||||||||||||||||||||||||||||
respiratory health | ||||||||||||||||||||||||||||||||||||||||||||
total chronic care | ||||||||||||||||||||||||||||||||||||||||||||
pain management: | ||||||||||||||||||||||||||||||||||||||||||||
acute pain | ||||||||||||||||||||||||||||||||||||||||||||
interventional pain | ||||||||||||||||||||||||||||||||||||||||||||
total pain management | ||||||||||||||||||||||||||||||||||||||||||||
total net sales | ||||||||||||||||||||||||||||||||||||||||||||
accrued rebates | ||||||||||||||||||||||||||||||||||||||||||||
accrued customer incentives | ||||||||||||||||||||||||||||||||||||||||||||
accrued sales returns | ||||||||||||||||||||||||||||||||||||||||||||
total estimated liabilities | ||||||||||||||||||||||||||||||||||||||||||||
first quarter of 2022 | ||||||||||||||||||||||||||||||||||||||||||||
second quarter of 2022 | ||||||||||||||||||||||||||||||||||||||||||||
net sales - percentage change | ||||||||||||||||||||||||||||||||||||||||||||
north america | ||||||||||||||||||||||||||||||||||||||||||||
europe, middle east and africa | ||||||||||||||||||||||||||||||||||||||||||||
asia pacific and latin america | ||||||||||||||||||||||||||||||||||||||||||||
gross profit margin | ||||||||||||||||||||||||||||||||||||||||||||
percentage of net sales | ||||||||||||||||||||||||||||||||||||||||||||
operating profit | ||||||||||||||||||||||||||||||||||||||||||||
operating profit margin | ||||||||||||||||||||||||||||||||||||||||||||
covid-19 related expenses | ||||||||||||||||||||||||||||||||||||||||||||
2020 restructuring charges | ||||||||||||||||||||||||||||||||||||||||||||
post divestiture restructuring charges | ||||||||||||||||||||||||||||||||||||||||||||
post divestiture transition charges | ||||||||||||||||||||||||||||||||||||||||||||
acquisition and integration-related charges | ||||||||||||||||||||||||||||||||||||||||||||
eu mdr compliance | ||||||||||||||||||||||||||||||||||||||||||||
litigation and legal | ||||||||||||||||||||||||||||||||||||||||||||
intangibles amortization | ||||||||||||||||||||||||||||||||||||||||||||
adjusted operating profit | ||||||||||||||||||||||||||||||||||||||||||||
exhibit number | ||||||||||||||||||||||||||||||||||||||||||||
3.1 | ||||||||||||||||||||||||||||||||||||||||||||
3.2 | ||||||||||||||||||||||||||||||||||||||||||||
4.3 | ||||||||||||||||||||||||||||||||||||||||||||
10.17 | ||||||||||||||||||||||||||||||||||||||||||||
10.18 | ||||||||||||||||||||||||||||||||||||||||||||
31 | ||||||||||||||||||||||||||||||||||||||||||||
32(a)* | ||||||||||||||||||||||||||||||||||||||||||||
32(b)* | ||||||||||||||||||||||||||||||||||||||||||||
101.ins | ||||||||||||||||||||||||||||||||||||||||||||
101.sch | ||||||||||||||||||||||||||||||||||||||||||||
101.cal | ||||||||||||||||||||||||||||||||||||||||||||
101.def | ||||||||||||||||||||||||||||||||||||||||||||
101.lab | ||||||||||||||||||||||||||||||||||||||||||||
101.pre | ||||||||||||||||||||||||||||||||||||||||||||
104 | ||||||||||||||||||||||||||||||||||||||||||||
avanos medical, inc. | ||||||||||||||||||||||||||||||||||||||||||||
august 9, 2022 | ||||||||||||||||||||||||||||||||||||||||||||
goodwill impairment | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||
net income on asset dispositions | 5,400,000 | 100,000 | 1,100,000 | |||||||||||||||||||||||||||||||||||||||||
proceeds from the sale of assets | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from rh divestiture post-closing settlement | 0 | 0 | 0 | 2,100,000 | ||||||||||||||||||||||||||||||||||||||||
investments in non-affiliates | -200,000 | -2,200,000 | -2,400,000 | |||||||||||||||||||||||||||||||||||||||||
payment of contingent consideration liabilities | 0 | -3,300,000 | 0 | -500,000 | 0 | |||||||||||||||||||||||||||||||||||||||
increase in cash and cash equivalents | -19,800,000 | 18,700,000 | -3,200,000 | 5,200,000 | -85,500,000 | -71,000,000 | -33,700,000 | -23,600,000 | -29,400,000 | 133,700,000 | 2,300,000 | -105,100,000 | 29,400,000 | 35,300,000 | 2,300,000 | -86,100,000 | 10,400,000 | 17,200,000 | 90,600,000 | |||||||||||||||||||||||||
stock-based compensation | ||||||||||||||||||||||||||||||||||||||||||||
goodwill and intangibles impairment | ||||||||||||||||||||||||||||||||||||||||||||
loss on rh disposal | ||||||||||||||||||||||||||||||||||||||||||||
net incomees on asset dispositions and asset impairments | ||||||||||||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities, net of acquisition | ||||||||||||||||||||||||||||||||||||||||||||
inventories, net of allowance | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from the rh divestiture | ||||||||||||||||||||||||||||||||||||||||||||
acquisition of assets and businesses, net of cash acquired | ||||||||||||||||||||||||||||||||||||||||||||
debt issuance costs | ||||||||||||||||||||||||||||||||||||||||||||
purchase of treasury stock | -1,900,000 | -300,000 | 0 | -500,000 | -100,000 | -1,600,000 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
cash and cash equivalents - beginning of year | ||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents - end of year | ||||||||||||||||||||||||||||||||||||||||||||
supplemental cash flow disclosure: | ||||||||||||||||||||||||||||||||||||||||||||
cash paid (refunded) for income taxes | ||||||||||||||||||||||||||||||||||||||||||||
cash paid for interest | ||||||||||||||||||||||||||||||||||||||||||||
supplemental noncash disclosure | ||||||||||||||||||||||||||||||||||||||||||||
capital expenditures included in accounts payable or accrued expenses | ||||||||||||||||||||||||||||||||||||||||||||
investment in note receivable | ||||||||||||||||||||||||||||||||||||||||||||
acquisition of minority interest investment | ||||||||||||||||||||||||||||||||||||||||||||
cash (used in) investing activities | ||||||||||||||||||||||||||||||||||||||||||||
cash refund for income taxes | ||||||||||||||||||||||||||||||||||||||||||||
senior secured revolving credit facility proceeds | 20,000,000 | |||||||||||||||||||||||||||||||||||||||||||
senior secured revolving credit facility repayments | -20,000,000 | |||||||||||||||||||||||||||||||||||||||||||
asset impairments | ||||||||||||||||||||||||||||||||||||||||||||
net incomees on asset dispositions | ||||||||||||||||||||||||||||||||||||||||||||
debt repayments | 0 | 0 | 0 | 0 | -299,000,000 | -40,000,000 | -1,000,000 | 0 | 0 | -50,000,000 | -1,000,000 | -10,900,000 | ||||||||||||||||||||||||||||||||
line of credit facility proceeds | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||
line of credit facility repayments | -35,000,000 | -10,000,000 | -35,000,000 | |||||||||||||||||||||||||||||||||||||||||
cash (refund) paid for income taxes | ||||||||||||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities: | ||||||||||||||||||||||||||||||||||||||||||||
net non-cash gain on divestiture | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from the divestiture | 0 | 18,400,000 | ||||||||||||||||||||||||||||||||||||||||||
cash paid for income taxes | ||||||||||||||||||||||||||||||||||||||||||||
acquisition of business, net of cash acquired | -100,000 | 100,000 | 0 | 100,000 | ||||||||||||||||||||||||||||||||||||||||
intercompany contributions | 0 | 0 | 0 | -26,100,000 | 26,600,000 | -17,400,000 | -5,100,000 | |||||||||||||||||||||||||||||||||||||
proceeds and excess tax benefits from the exercise of stock options | ||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rate on cash and cash equivalents | ||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents, beginning of period | 0 | 0 | 0 | 303,900,000 | 0 | 0 | 0 | 114,500,000 | -38,100,000 | 0 | 0 | 0 | -8,800,000 | 101,100,000 | 0 | 0 | ||||||||||||||||||||||||||||
cash and cash equivalents, end of period | 5,200,000 | -85,500,000 | -71,000,000 | 270,200,000 | -23,600,000 | 85,100,000 | 95,600,000 | 2,300,000 | 35,300,000 | 2,300,000 | -94,900,000 | 111,500,000 | 12,500,000 | -13,800,000 | ||||||||||||||||||||||||||||||
dividend received from subsidiaries | ||||||||||||||||||||||||||||||||||||||||||||
cash dividends paid to guarantor | ||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rate on cash, cash equivalents and restricted cash | ||||||||||||||||||||||||||||||||||||||||||||
increase in cash, cash equivalents and restricted cash | ||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash, end of period | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from dispositions of property | ||||||||||||||||||||||||||||||||||||||||||||
defined benefit plans | 200,000 | |||||||||||||||||||||||||||||||||||||||||||
cash flow hedges | 700,000 | |||||||||||||||||||||||||||||||||||||||||||
total other comprehensive income, net of tax | 10,700,000 | |||||||||||||||||||||||||||||||||||||||||||
prepaid expenses and other current assets | 16,700,000 | |||||||||||||||||||||||||||||||||||||||||||
common stock - 0.01 par value - authorized 300,000,000 shares, 46,695,242 outstanding at march 31, 2017 and 46,681,798 outstanding at december 31, 2016 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||
net loss on asset dispositions | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from property dispositions | 7,700,000 | |||||||||||||||||||||||||||||||||||||||||||
net (gain) loss on asset dispositions | -12,100,000 | |||||||||||||||||||||||||||||||||||||||||||
debt proceeds | 636,100,000 | |||||||||||||||||||||||||||||||||||||||||||
change in kimberly-clark's net investment | ||||||||||||||||||||||||||||||||||||||||||||
current deferred income taxes | ||||||||||||||||||||||||||||||||||||||||||||
assets held for sale | ||||||||||||||||||||||||||||||||||||||||||||
liabilities and equity | ||||||||||||||||||||||||||||||||||||||||||||
debt payable within one year | ||||||||||||||||||||||||||||||||||||||||||||
related party debt | ||||||||||||||||||||||||||||||||||||||||||||
preferred stock—0.01 par value—authorized 20,000,000 shares, none issued | ||||||||||||||||||||||||||||||||||||||||||||
common stock—0.01 par value—authorized 300,000,000 shares in 2014; 46,535,951 outstanding at december 31, 2014 | ||||||||||||||||||||||||||||||||||||||||||||
kimberly-clark’s net investment | ||||||||||||||||||||||||||||||||||||||||||||
retained earnings | ||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive income | ||||||||||||||||||||||||||||||||||||||||||||
balance at december 31, 2011 | ||||||||||||||||||||||||||||||||||||||||||||
change in kimberly-clark’s investment | ||||||||||||||||||||||||||||||||||||||||||||
unrealized translation | ||||||||||||||||||||||||||||||||||||||||||||
cash flow hedges, net of tax of 0.3 | ||||||||||||||||||||||||||||||||||||||||||||
balance at december 31, 2012 | ||||||||||||||||||||||||||||||||||||||||||||
cash flow hedges, net of tax of 1.7 | ||||||||||||||||||||||||||||||||||||||||||||
balance at december 31, 2013 | ||||||||||||||||||||||||||||||||||||||||||||
spin-off cash distribution to kimberly-clark | ||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock and consummation of spin-off | ||||||||||||||||||||||||||||||||||||||||||||
cash flow hedges, net of tax of 0.7 | ||||||||||||||||||||||||||||||||||||||||||||
balance at december 31, 2014 | ||||||||||||||||||||||||||||||||||||||||||||
share-based compensation | ||||||||||||||||||||||||||||||||||||||||||||
provision for losses on accounts receivable and inventories | ||||||||||||||||||||||||||||||||||||||||||||
deferred income taxes | -21,100,000 | |||||||||||||||||||||||||||||||||||||||||||
amortization of debt issue costs and debt discount | ||||||||||||||||||||||||||||||||||||||||||||
net losses on asset dispositions | ||||||||||||||||||||||||||||||||||||||||||||
cash outflows for acquisitions | ||||||||||||||||||||||||||||||||||||||||||||
deposit received on pending sale of assets | ||||||||||||||||||||||||||||||||||||||||||||
net transfers from (to) kimberly-clark | ||||||||||||||||||||||||||||||||||||||||||||
share-based compensation charged by kimberly-clark | ||||||||||||||||||||||||||||||||||||||||||||
benefit from losses on accounts receivable and inventories | ||||||||||||||||||||||||||||||||||||||||||||
asset impairment | ||||||||||||||||||||||||||||||||||||||||||||
changes in operating working capital: | ||||||||||||||||||||||||||||||||||||||||||||
decrease (increase) in accounts receivable | ||||||||||||||||||||||||||||||||||||||||||||
increase in inventories | ||||||||||||||||||||||||||||||||||||||||||||
increase in trade accounts payable | ||||||||||||||||||||||||||||||||||||||||||||
decrease in accrued expenses | ||||||||||||||||||||||||||||||||||||||||||||
decrease in accrued income taxes | ||||||||||||||||||||||||||||||||||||||||||||
capital spending | ||||||||||||||||||||||||||||||||||||||||||||
cash outflows for acquisitions and investments |